{"id":"W2906110772","doi":"10.1016/j.jval.2018.09.103","title":"PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Oncology; Population; Internal medicine; Lung cancer; Hazard ratio; Regimen; Cancer; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003886723,0.0002317114,0.001175008,0.0002656139,0.0001594581,0.000006853971,0.0001261497,0.00007416299,0.00001140379],"category_scores_gemma":[0.0001672756,0.0001912435,0.00007984455,0.0005480672,0.0001733413,0.00005608425,0.00006740109,0.0002616286,3.846464e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002057799,"about_ca_system_score_gemma":0.001251621,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01169553,"about_ca_topic_score_gemma":0.006210244,"domain_scores_codex":[0.9973758,0.0002355895,0.0008408102,0.0003919611,0.0006716358,0.0004841499],"domain_scores_gemma":[0.9972649,0.0004199771,0.000657114,0.0003127842,0.001190259,0.0001549957],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04109904,0.000664835,0.9140003,0.00738538,0.0002427482,7.396264e-7,0.02496411,0.008948583,0.00002403611,0.00002109081,0.0006035455,0.002045569],"study_design_scores_gemma":[0.06411465,0.03882881,0.8259701,0.008364224,0.0005531576,4.431797e-7,0.004950089,0.0518452,0.004460738,0.00001080411,0.0003772451,0.0005245207],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890323,0.00634644,0.0001515875,0.00009897136,0.0004574448,0.003387596,0.0004132257,0.00002639164,0.00008609857],"genre_scores_gemma":[0.9954286,0.0002068426,0.003952651,0.00001743719,0.0001543348,0.0000600201,0.0001406193,0.00003131657,0.000008143073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08803019,"threshold_uncertainty_score":0.9948857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.146381492280194,"score_gpt":0.4403910053062912,"score_spread":0.2940095130260972,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}